- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.09. | GTCR to acquire generic drug maker Zentiva | ||
| 12.09. | MSD calls off £1bn UK expansion amid government-big pharma tensions | ||
| 12.09. | Kashiv signs deal with CRISTÁLIA for Xolair biosimilar in LATAM | ||
| 11.09. | UK pharma industry risks losing world-leading status as investment plummets | ||
| 11.09. | Trump tasks FDA to crack down on misleading drug advertising | ||
| 11.09. | Kriya gains $320m in Series D for gene therapy development | ||
| 11.09. | Sanofi's Tzield gains approval in China for T1D management | ||
| 10.09. | Novo Nordisk slashes 11% of workforce as Eli Lilly pressure tightens | ||
| 10.09. | Health Canada approves Medison and Ipsen's Bylvay to treat ALGS | ||
| 10.09. | Capricor refutes FDA's DMD deramiocel rejection in public statement | ||
| 10.09. | Kytopen and BlueWhale Bio partner for cell therapy innovation | ||
| 09.09. | Novartis snaps up promising ASCVD asset with Tourmaline acquisition | ||
| 09.09. | US Government signs $56m smallpox/mpox vaccine order despite political disarray | ||
| 09.09. | Servier to acquire potential Fragile X syndrome treatment from Kaerus | ||
| 09.09. | Novo's Ozempic price cut expected to slow market share erosion | ||
| 09.09. | WHO adds GLP-1RAs to essential medicines list | ||
| 09.09. | Epigenic raises $60m for epigenetic treatment development | ||
| 08.09. | MD Anderson and Phoenix to advance cell and gene therapy tech | ||
| 08.09. | Hengrui Pharma signs deal with Braveheart Bio for HRS-1893 | ||
| 05.09. | Cystic fibrosis market forecast to reach $16.0bn by 2034 in the 7MM | ||
| 05.09. | Comparator sourcing: Essential information from Oximio - podcast | ||
| 05.09. | Multiply Labs' biomanufacturing robot to "slash cell therapy costs" | ||
| 05.09. | Five takeaway quotes from RFK Jr's combative Senate hearing | ||
| 05.09. | EMA warns of rise in illegal weight loss drugs marketed online | ||
| 05.09. | MRM Health gains $64m for microbiome-based biotherapeutic pipeline |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .